Drug Updates

Drug updates provide the latest information and relevant warnings and notifications.

Update on Drugs and Drug News: January 2002

Update on: Pimecrolimus Elidel®Butenafine HCl 1% Cream Lotrimin Ultra®Doxycycline Vibramycin®Fluocinolone acetonide Derma-Smoothe/FS®Doxycycline Thalidomid®

Update on Drugs & Devices: September – October 2019

The latest drug & device update covers: Adalimumab-bwwd for SC injection (Hadlima™), Apremilast tablets (Otezla®), Calcipotriene + betamethasone dipropionate (Enstilar® foam Taclonex® topical suspension), Bempegaldesleukin + nivolumab for IV use (NKTR-214 + Opdivo®), Dupilumab for SC injection (Dupixent®), Magnetic muscle stimulation for body contouring (CoolTone™), Laser device for body contouring (eon™ FR).

2020 Index for Skin Therapy Letter – Dermatology Edition

This index covers all new skin treatments introduced in Skin Therapy Letter Dermatology Edition articles in 2020.

Update on Drugs and Drug News: September 2008

Update on Certolizumab pegol Cimzia® UCB S.A., Golimumab Centocor, Ceftobiprole medocaril ZEFTERA® Basilea Pharmaceuticals, and Tipranavir Aptivus® Boehringer-Ingelheim.

Update on Drugs & Devices: March – April 2020

This update covers Tazemetostat tablets/Tazverik™ (Epizyme, Inc.), Tazarotene lotion 0.045%/Arazlo™ (Ortho Dermatologics, Bausch Health) and Rituximab biosimilar for IV injection/ABP 798 (Amgen, Allergan).

Update on Drugs and Drug News: September-October 2013

Update on Dabrafenib mesilate capsule (Tafinlar™), Trametinib dimethyl sulfoxide tablet (Mekinist™), and Vismodegib capsule (Erivedge®)

Update on Drugs and Drugs News April 2005

Updates on: Clinical Phototherapy System ClearTouch™ Light Unit Assembly Adalimumab HUMIRA® Dalbavancin Vicuron MDX-010 Medarex Clindamycin Evoclin® Foam 1%

Update on Drugs and Drug News – September 2006

Update on Quadrivalent Human Papillomavirus Recombinant Vaccine GARDASIL®, Infliximab Remicade®, Humira® Penq, and news about Malignant Melanoma and Scleroderma research.

Update on Drugs & Devices: March-April 2022

This update covers Adalimumab biosimilar - Yuflyma™ (Celltrion Healthcare), Adalimumab biosimilar - Simlandi™ (Alvotech/JAMP Pharma), Abrocitinib tablet - Cibinqo® (Pfizer), Upadacitinib tablet - Rinvoq® (AbbVie), Risankizumab-rzaa SC injection - Skyrizi® (AbbVie), and HA-based dermal filler - Juvéderm® Volbella® XC (AbbVie/ Allergan Aesthetics).

Update on Drugs and Drug News: January, 1998

Update on: Norgestimate / Ethinylestradiol Tri-Cyclen® Lidocaine/Prilocaine Cream Emla®Tretinoin gel 0.025% Avita® Adapalene solution 0.1% Differin®Topical tissue adhesive Dermabond® Atorvastin calcium Lipitor® Isotretinoin Accutane®

Update on Drugs and Drug News – October 2006

Update on Ketoconazole 2% Gel Xolegel™, Famciclovir Tablets Famvir®, Ecamsule 2% + Avobenzone 2%/ Octocrylene 10% Cream Anthelios SX®, and news about lice treatment.

Update on Drugs & Devices: March – April 2019

Latest drug update covers Pembrolizumab, Oral JAK + SYK dual inhibitor, Lidocaine 7% + tetracaine 7% local anesthetic cream and PrabotulinumtoxinA-xvfs.

Update on Drugs & Devices: September – October 2018

Updates on Binimetinib + Encorafenib (Mektovi® + Braftovi®), Crisaborole 2% ointment (Eucrisa™), Glycopyrronium tosylate 2.4% cloth (Qbrexza™), Secukinumab for SC injection (Consentyx®), Tecovirimat capsule (Tpoxx), Diacerein 1% ointment (CCP-020), Migalastat capsule (Galafold™), Mogamulizumabkpkc for IV use (Poteligeo®)

Update on Drugs & Drug News October 2005

Updates on: Tigecycline Tygacil™ Terbinafine HCl Lamisil® Tablets Moxifloxacin HCl Avelox® Adalimumab Humira®

Update on Drugs and Drug News: November-December 2017

November-December 2017 Update on drugs includes Adalimumab-adbm for SC injection Cyltezo™, Adalimumab biosimilar Imraldi®, Cemiplimab REGN2810, Oral migalastat Galafold™, and Secnidazole oral granules Solosec™

Update on Drugs and Drug News: January 2001

Update on: Lamivudine, Zidovudine and Abacavir Trizivir Loratidine Claritin Amlexanox 5% paste AptheraBotulinum toxin type B Myobloc

Update on Drugs and Drug News: November-December 2014

Update on Omalizumab (Xolair®), Pembrolizumab (Keytruda®), Oritavancin (Orbactiv™), and Calcipotriene 0.005% + betamethasone dipropionate 0.064% topical suspension (Taclonex®)

Update on Drugs and Drug News: July 2012

Update on drugs, approval dates, and comments. CIP-Isotretinoin (Absorica™), Tazarotene 0.1% foam (Fabior™), Butoconazole nitrate 2% vaginal cream, Multisource radiofrequency aesthetic device (Glow by EndyMed™), Low-level laser for circumferential upper arm reduction (Zerona®) are covered.

Update on Drugs and Drug News: January 2000

Update on: Pyrethrins/Piperonyl butoxide Rid aerosol foam mousse Fluocinolone acetonide 0.01% Derma-Smoothe/FS Quinupristin/ Dalfopristin Synercid IV Rid Lice Egg Loosener Gel Tacrolimus Protopic Ointment Docosanol

Update on Drugs and Drug News: May-June 2017

Update on Dupilumab for SC injection Dupixent®, Dupilumab for SC injection, Avelumab for IV injection Bavencio®, Hyaluronic acidbased injectable dermal filler Juvéderm®, Biosimilar to adalimumab for SC injection Amgevita™ Vollure™ XC, Adalimumab for SC injection Humira®, and Amgevita™.

Update on Drugs and Drug News: December, 1996

Update on: Amphotericin B Lipid Complex Injection Abelcet®Butenafine HCl Cream 1% Mentax® Itraconazole Sporanox®Acitretin Soriatane® Penciclovir cream 1% Denavir®Valacyclovir Valtrex®Laser device Sharplan Silktouch laser®Permethrin lotion Nix®Ivermectin Mectizan® (6 mg tablet)

Update on Drugs and Drug News: March, 2000

Update on: Tissue Engineered Collagen Matrix Oasis Wound Dressing Bexarotene Targretin Gel 1% Eflornithine Hydrochloride Vaniqa Cream 15% Biologically Active Dressing Composite Cultured Skin (CCS) Famciclovir Famvir Moxifloxacin Avelox/Avalox Finasteride 1mg Tablets Propecia

Update on Drugs and Drug News – June 2006

Update on Minocycline HCl SOLODYN™ Extended Release Tablets, Linezolid ZYVOX® 600mg, Tigecycline Tygacil®, and CF-1743.

Update on Drugs and Drug News: September-October 2015

Update on Nivolumab IV infusion (Opdivo®), Pembrolizumab IV infusion (Keytruda®), Sonidegib phosphate capsules (Odomzo®), Azelaic acid 15% foam (Finacea® Foam), Adapalene 0.3% + benzoyl peroxide 2.5% gel (Epiduo® Forte), Deoxycholic acid injection (Belkyra™), Hyaluronic acid gel injectable dermal filler (Restylane® Lyft with Lidocaine), Dermal filler with calcium hydroxylapatite (CaHA) + integral 0.3% lidocaine (Radiesse® (+)

Update on Drugs and Drug News: May 2001

Update on: Moxifloxacin HCl Avelox Recombinant Human Iduronidase (IDUA) Neurotoxins Botox Graftskin Apligraf

Update on Drugs & Devices: January-February 2021

The latest drug & device update covers: Orladeyo™ (BioCryst Pharmaceuticals), KPL-716 (Kiniksa Pharmaceuticals), Sklice® (Arbor Pharmaceuticals) and Picato® (Leo Pharma)

Update on Drugs and Drug News: January 2011

Update on drugs, approval dates, and comments. Calcipotriene/Calcipotriol0.005% foam (Sorilux™), Ceftaroline fosamil (Teflaro™) are covered as well as an update on Health Canada on the use of tacrolimus (Protopic®) for atopic dermatitis.

Update on Drugs and Drugs News June 2005

Updates on: Pimecrolimus and Tacrolimus Elidel® Cream and Protopic® Ointment Elidel®: Novartis Protopic®: Miltefosine Impavido®

POPULAR

Advertisement